Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% |
|
-.--% | -.--% |
2024 | ThermoGenesis Holdings, Inc. Announces Resignation of Jeffery Cauble as Chief Financial Officer | CI |
2024 | ThermoGenesis Holdings, Inc. Receives A Notice of Default from Boyalife Group, Inc | CI |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Therapeutic Devices | ||||||||||
Device | 12.96M | 9.74M | - | 10.48M | 9.44M | |||||
Total Assets | 13.42M | 20.86M | - | 19.39M | 11.23M | |||||
Interest Expense | - | -7.91M | - | -5.62M | -10.03M | |||||
CAPEX | - | -23K | - | -400K | -1.73M | |||||
EBT | - | -16.35M | - | -11.27M | -17.98M | |||||
Gross Profit | 5.78M | 1.26M | - | 2.71M | 1.93M | |||||
EBITDA | - | - | - | - | - | |||||
D&A | 530K | 742K | - | 926K | 1.15M | |||||
Operating Income | -1.3M | -8.9M | - | -6.19M | -8.61M | |||||
Net Income | - | -16.35M | - | -11.27M | -17.98M | |||||
Protein and Genome Sequence Products | ||||||||||
Clinical Development | 90K | - | - | - | - | |||||
Total Assets | 1.79M | - | - | - | - | |||||
Gross Profit | -86K | - | - | - | - | |||||
EBITDA | - | - | - | - | - | |||||
D&A | 275K | - | - | - | - | |||||
Operating Income | -3.43M | - | - | - | - | |||||
Cryogenic Equipment | ||||||||||
Surgical & Medical Equipment | - | - | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Net Income | - | - | - | - | - |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
United States | 6.79M | - | - | 6.64M | 6.03M | |||||
Total Assets | 1.11M | 810K | 647K | - | - | |||||
Other | 573K | - | - | 798K | 2.52M | |||||
Total Assets | 113K | 55K | 183K | - | - | |||||
United Arab Emirates | - | - | - | - | 570K | |||||
Vietnam | - | - | - | 515K | 225K | |||||
China | 2.35M | - | - | 1.98M | 98K | |||||
Total Assets | - | - | - | - | - | |||||
South Korea | - | - | - | 536K | - | |||||
Thailand | - | - | - | 9K | - | |||||
Asia - Other | 2.11M | - | - | - | - | |||||
Total Assets | 225K | 169K | 139K | - | - | |||||
Hong Kong | - | - | - | - | - | |||||
South America | - | - | - | - | - | |||||
Total Assets | 582K | 390K | 292K | - | - | |||||
Europe | 1.23M | - | - | - | - |
- Stock Market
- Equities
- THMO Stock
- Financials ThermoGenesis Holdings, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions